Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Department of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Adv Exp Med Biol. 2018;1063:149-165. doi: 10.1007/978-3-319-77736-8_11.
Cancer-associated fibroblasts (CAFs), a major component of the tumor microenvironment (TME), play an important role in cancer initiation, progression, and metastasis. Recent findings have demonstrated that the TME not only provides physical support for cancer cells, but also directs cell-to-cell interactions (in this case the interaction between cancer cells and CAFs). As cancer progresses, the CAFs also co evolve—transitioning from an inactivated state to an activated state. The elucidation and understanding of the interaction between cancer cells and CAFs will pave the way for new cancer therapies [1–3]. The TME is a heterogeneous environment consisting of fibroblasts, tumor-associated macrophages, adipocytes, an extracellular matrix, and mesenchymal stem cells [4]. The exact composition of each stroma varies depending on cancer and tissue type. To add to this variation, there is heterogeneity even within the CAF population itself. Different CAFs express different markers and influence stromal pro-tumorigenic capacity and cancer progression in diverse ways [5, 6].
癌症相关成纤维细胞(CAFs)是肿瘤微环境(TME)的主要组成部分,在癌症的发生、发展和转移中起着重要作用。最近的研究结果表明,TME 不仅为癌细胞提供了物理支持,还指导了细胞间的相互作用(在这种情况下是癌细胞和 CAFs 之间的相互作用)。随着癌症的进展,CAFs 也共同进化——从失活状态转变为激活状态。阐明和理解癌细胞和 CAFs 之间的相互作用将为新的癌症治疗方法铺平道路[1-3]。TME 是一个异质的环境,由成纤维细胞、肿瘤相关巨噬细胞、脂肪细胞、细胞外基质和间充质干细胞组成[4]。每种基质的确切组成取决于癌症和组织类型。除此之外,CAF 群体本身也存在异质性。不同的 CAFs 表达不同的标记物,并以不同的方式影响肿瘤促进能力和癌症进展[5,6]。